ArticleScientific reports2023
MANet: a multi-attention network for automatic liver tumor segmentation in computed tomography (CT) imaging.
Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- A Systematic Review of Deep Learning Approaches for Hepatopancreatic Tumor Segmentation.Journal of imaging · 2026Review
- Article
- Deep learning for automatic segmentation of hepatocellular carcinoma in contrast enhanced CT scans.Scientific reports · 2025Article
- FSS-ULivR: a clinically-inspired few-shot segmentation framework for liver imaging using unified representations and attention mechanisms.Journal of cancer research and clinical oncology · 2025Article
- A deep learning-based computed tomography reading system for the diagnosis of lung cancer associated with cystic airspaces.Scientific reports · 2025Article
- Comprehensive multi-phase 3D contrast-enhanced CT imaging for primary liver cancer.Scientific data · 2025Article
- Improved SwinUNet with fusion transformer and large kernel convolutional attention for liver and tumor segmentation in CT images.Scientific reports · 2025Article
- From CNNs to SAM: A Survey of Deep Learning Techniques for Liver Tumor Segmentation in CT Images.IEEE access : practical innovations, open solutions · 2025Article
- A review of deep learning approaches for multimodal image segmentation of liver cancer.Journal of applied clinical medical physics · 2024Review
- Artificial intelligence techniques in liver cancer.Frontiers in oncology · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Automatic liver tumor segmentation is a paramount important application for liver tumor diagnosis and treatment planning. However, it has become a highly challenging task due to the heterogeneity of the tumor shape and intensity variation. Automatic liver tumor segmentation is capable to establish the diagnostic standard to provide relevant radiological information to all levels of expertise. Recently, deep convolutional neural networks have demonstrated superiority in feature extraction and learning in medical image segmentation. However, multi-layer dense feature stacks make the model quite inconsistent in imitating visual attention and awareness of radiological expertise for tumor recognition and segmentation task. To bridge that visual attention capability, attention mechanisms have developed for better feature selection. In this paper, we propose a novel network named Multi Attention Network (MANet) as a fusion of attention mechanisms to learn highlighting important features while suppressing irrelevant features for the tumor segmentation task. The proposed deep learning network has followed U-Net as the basic architecture. Moreover, residual mechanism is implemented in the encoder. Convolutional block attention module has split into channel attention and spatial attention modules to implement in encoder and decoder of the proposed architecture. The attention mechanism in Attention U-Net is integrated to extract low-level features to combine with high-level ones. The developed deep learning architecture is trained and evaluated on the publicly available MICCAI 2017 Liver Tumor Segmentation dataset and 3DIRCADb dataset under various evaluation metrics. MANet demonstrated promising results compared to state-of-the-art methods with comparatively small parameter overhead.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.